Podcasts about Beckman Coulter

*Hosted by Andrei Palamariu*Together with Chad Hawkinson, Chief Innovation Officer at Baxter Planning, we discussed the current trends and innovations in the service supply chain space. Chad shared how Baxter Planning helps companies optimize spare parts management, reducing inventory by 25% and saving customers over $500 million in 2024. We also discussed their focus on AI and machine learning for forecasting and digital twin simulations to improve resiliency. Some of their notable successes include a 20% improvement in first-time fix rates for Beckman Coulter. Chad also shared some of their upcoming products, including real-time visibility tools, AI-driven ETAs, and a module for budget-constrained planning. He also emphasized the importance of specialized solutions for service parts management.Discover more details here.Follow us on:Instagram: http://bit.ly/2Wba8v7Twitter: http://bit.ly/2WeulzXLinkedin: http://bit.ly/2w9YSQXFacebook: http://bit.ly/2HtryLd

Diagnostics firm Beckman Coulter has announced 80 jobs in Clare as well as a €10 million investment into its operations here. The announcement was made at an event at the company's facility outside O'Callaghan's Mills where 560 people are already employed. One of those in attendance was European Commissioner designate and Fianna Fáil TD Michael McGrath. Clare FM's Seán Lyons caught up with the former Finance Minister to get his thoughts.

The European Commissioner designate has expressed confidence there'll be "more and more opportunities for industrial development" in Clare in the coming years. Fianna Fáil's Michael McGrath has visited the east Clare Beckman Coulter facility where a major jobs boost as well as a significant investment have been announced. Located on the outskirts of O'Callaghan's Mills, the Beckman Coulter facility is the largest employer in east Clare - supporting 560 jobs. Last year, employment generated by the company had an employment income impact of €55 million. Specialising in advanced diagnostics, Beckman Coulter is one the top three diagnostics companies worldwide and employs over 11,000 people around the world. This week, the firm has announced a €10 million investment in this county which will support the addition of two new fully automated reagent filling lines and upgrades to the site's infrastructure. Additionally, it's hiring for 50 roles and expect 30 additional jobs to be created in the near future. Beckman Coutler President Kevin O'Reilly insists more growth is expected as the company's star rises further. The announcement at the east Clare facility was attended by former Minister for Finance and European Commissioner designate Michael McGrath. The Fianna Fáil politician says due to Clare's strategic location, more employers like Beckman Coulter must be incentivised to come to the county. A recent meeting of West Clare's local representatives heard Kilmurry Ibrickane Fianna Fáil Councillor Michael Shannon call for more industrial hubs like Shannon's Smithstown Industrial Estate to be created countywide. Tulla Fianna Fáil Senator Timmy Dooley believes people in Clare ideally shouldn't have to travel far to reach their place of employment.

The announcement at the east Clare facility was attended by former Minister for Finance and European Commissioner designate Michael McGrath. The Fianna Fáil politician says due to Clare's strategic location, more employers like Beckman Coulter must be incentivised to come to the county. A recent meeting of West Clare's local representatives heard Kilmurry Ibrickane Fianna Fáil Councillor Michael Shannon call for more industrial hubs like Shannon's Smithstown Industrial Estate to be created countywide. Tulla Fianna Fáil Senator Timmy Dooley believes people in Clare ideally shouldn't have to travel far to reach their place of employment.

On today's show, independent researchers and writers John Beaudoin Sr. and Kevin McKernan review Steve Kirsch's recent 'data bombshell' speech at MIT and take turns sharing their expert analysis of the pandemic and the subsequent jabs. John and Kevin each tell their remarkable stories of how they were able to recognize the scam of the pandemic early on, as a result of their respective fields of study. Also, John shares a profound and personal story, and Kevin explains some of his pioneering scientific work in the field of therapeutic cannabis. GUEST 1 OVERVIEW: John Paul Beaudoin, Sr. is an American author and father of three men for whom he spent all of his meaningful life caring. John has a Master's degree in Business Administration and a Bachelor's degree in Computer & Systems Engineering. After more than thirty (>30) years developing and executing campaigns for contracts in the electronics and semiconductors research and development industry, John lost his eldest son at twenty (20) years old in a motorcycle accident. Two (2) years afterward, the covid era began. John simply wanted truth and could not find it in government data, media announcements, press releases, or local conversations. He sought a signal amongst the noise. John knew that things were not as we were programmed to believe. Having been in sales and marketing, he recognized the tactics used against the populace. Three (3) and four (4) word catch phrases were repeated ad nauseam on television and social media. This is programming, marketing, advertising, manipulation, propaganda. “Two weeks to flatten the curve” “Safe and effective” “I wear my mask for you” “Six feet” “Antivaxers are selfish” “Don't kill grandma” “Correlation doesn't equal causation” John recognizes these mass manipulation tactics and strategies because he sees first-hand the outcome of such manipulation. He sees the world from a viewpoint of interrelated systems. When orders were given to lock down, social distance, mask, or vaccinate, John knew immediately the negative externalities that would ensue. Some people are frail in physical and mental health. Stark societal changes will maim or kill those at the margins of health. Given John's horizontal aptitude, he was a good fit for the problem. His insight is gleaned from his years of problem solving from an engineering point of view. This includes a unique and cursory knowledge across a wide range of disciplines including : psychology, sociology, economics, law, finance, accounting, physical sciences, electrical engineering. John is one of a handful of people with the record-level source data and the systems-level vision to pull it all together into a broad understanding of how this covid era came to be. https://substack.com/@coquindechien https://twitter.com/JohnBeaudoinSr GUEST 2 OVERVIEW: Kevin McKernan is the CSO and Founder of Medicinal Genomics and has pioneered the genomics of cannabis and hemp to build a stronger scientific environment (Kannapedia.net) for the study of cannabis based therapeutics and blockchain technologies for tracking and verifying cannabis genetics. Previously, Kevin was the CSO of Courtagen Life Sciences, Inc., and was Vice President and Director of R&D of Life Technologies where he managed the development of Life Technologies next generation SOLiD sequencing technology. Integral to the SOLiD R&D process, Kevin oversaw over 100 research collaborations exploring the new biological frontiers with next generation sequencing and saw particular excitement and traction in human tumor sequencing. Kevin initiated an R&D project to investigate chemFET semiconductor based DNA sequencing and spearheaded a process to acquire the DNA sequencing company Ion Torrent for $350M. These collaborations resulted in hundreds of publications and 7 Journal covers from Science Translational Medicine to Nature. Kevin was the President and CSO of Agencourt Personal Genomics, a startup company he co-founded in 2005 to invent revolutionary sequencing technologies that dropped the cost of sequencing a human genome from $300M to $3,000; a 100,000-fold improvement in sequencing speed and cost in a few years. In 2000, Kevin Co-Founded Agencourt Biosciences Corporation and acted as the CSO until it was acquired by Beckman Coulter. Kevin also managed the R&D for the Human Genome Project at Whitehead Institute/MIT resulting in several patents for nucleic acid purification. Kevin holds a B.S. in Biology from Emory University with a focus on cloning and expressing Norepinephrine Transporters. When not decoding DNA and unraveling the mysteries of cannabis medicine, Kevin enjoy boating, skiing, and gardening. https://substack.com/@kevinmckernan https://twitter.com/Kevin_McKernan

The Emergency Department is perhaps the singular environment in a hospital where the greatest concentration of decisions are made with the least amount of clinical data; and the acuity-level assigned at triage can massively impact the trajectory of care for apatient. Additionally, Emergency Departments in the United States have experiencedunprecedented levels of crowding over the last two decades, with correlation to worsened patient outcomes, preventable errors, and staff burnout.In 2017, the ED at Johns Hopkins deployed a CDS tool that leverages AI to generaterisk-driven triage acuity recommendations, instead of relying on resource-based ESI. The tool has provided more reliable detection of patients with critical illness and reduced the time patients wait for care. They've also seen marked decrease in those assigned to the mid-acuity level 3, and instead more utilization of the low-acuity levels 4 and 5, which lends to better fast-track throughput for those patients who are to be discharged.Jeremiah Hinson, MD PhD, will speak of his experience developing and utilizing the toolwith his team at Johns Hopkins.

The Flow Stars podcast from Beckman Coulter and Bitesize Bio, hosted by Peter O'Toole (University of York), is back for a fourth season. Bringing you closer to the big hitters in flow cytometry, we get to know the leaders in the field outside of the lab.Join Peter as he talks to some of the big hitters in flow cytometry, including Jessica Houston, Paul Wallace, Pratip Chattopadhyay, Peter Lopez, Jessica Back, Ryan Brinkman, Alexis Perez Gonzalez, Karen Hogg, and Margaret Mbuchi!Watch all episodes on YouTube here: https://youtube.com/playlist?list=PLvFacfba2WccXyWuhTGEb8h7ViKv04jbU&feature=shared

In this podcast episode, host Gary introduces Daniel Callahan, a highly successful trial attorney, and discusses his career and achievements. Daniel shares insights on being a successful trial attorney, emphasizing the importance of putting clients first, being prepared, and having confidence. They also discuss the challenges trial attorneys face, the role of creativity in trial work, and the significance of personal freedom and fulfillment in the legal profession. Daniel provides advice about starting a law firm and building strong relationships with clients and opposing counsel. The episode concludes with Gary and Daniel emphasizing the importance of enjoying life and nurturing relationships. Throughout his career, Daniel J. Callahan has always been known as one of the top trial attorneys in California.  His notable jury verdicts included a $934,000,000 jury verdict obtained after a three-month jury trial in a complex business dispute entitled Beckman Coulter vs. Flextronics. This unanimous verdict was the largest in California in 2003 and remains the largest in Orange County history. Mr. Callahan also went on to obtain a $50,000,000 settlement in a road design case against the City of Dana Point. Exclusive of large class actions, this continues to be the largest personal injury settlement in United States history. Mr. Callahan also obtained, after a two-month jury trial, a $38 Million settlement on behalf of a class of newspaper delivery drivers against The Orange County Register. This is still the highest employment settlement in Orange County's history. Mr. Callahan grew up in Chicago, Illinois where he went on to receive his BA, magna cum laude, from Western Illinois University in 1976, and graduated with honors from the UC Davis School of Law in 1979, while serving as Editor of the Law Review. He began his career in Hawaii before relocating to Southern California and starting his own firm by opening the doors on St. Patrick's Day, 1984. Mr. Callahan also provides corporate consulting to law firms and lawyers regarding litigation and strategy through Callahan Consulting Group, LLC.

On this episode of the SPOT Radio® Podcast Charlie Webb CPPL speaks with Elon Goldbaum about the value of medical device packaging inspection and testing in order to monitor process value. Guest bioElon Goldbaum is Vice President, Packaging Engineering & Client Solutions, Lon has over 20 years of experience in the MedTech and Pharmaceutical industries, specializing in packaging, labeling, quality, CAPA systems, and sterilization. Lon is focused on business development for growing the Network Partners packaging engineering organization and commercial sales.Prior to joining Network Partners, Lon held various roles with Beckman Coulter, Baxter Healthcare, Edwards Lifesciences, Endologix,  and Danaher with a wide range of responsibilities. Lon earned his Bachelor of Science degree in Packaging from Michigan State University.E-mail: elon.goldbaum@networkpartners.comWebsite: http://www.networkpartners.com/Linkedin: https://www.linkedin.com/company/network-packaging-partners/

On this episode of Investor Connect, Hall welcomes Bentley Adams, CEO & Founder at Way. Located in Los Angeles, CA, Way is an intuitive eating app that helps people find peace in their relationships with food and their body. Their mission is to impact health and happiness, with a vision of the future where restrictive diets are a thing of the past - where people discuss listening to their body instead of what diet plan they're failing on. Through simple, thought-provoking questions and sessions that incorporate intuitive eating practices and apply them within the CBT framework, Way has helped 73% of users think differently about how they eat or actually eat differently (i.e. at the grocery store or restaurant), in the first week. Most apps struggle to get 10% of customers to benefit, ever. Bentley is a mission-oriented, three-time health entrepreneur. The first company was a VC-backed laboratory management company that exited successfully to Private Equity and the second company was a digital marketing agency focused on the consumerization of healthcare and became an Inc. 500 company. Earlier in his career he was a top producer for Beckman Coulter and audited Medicaid while at KPMG, but his passion has always stemmed from his mission to impact health and happiness and his college minor studying physiology, functional movement, and the emotional and psychological layers of helping people find lasting behavior change that betters their whole life, health, and happiness. Bentley shares the unique approach and differentiation of his company, from its competitors Unlike restrictive diets, Way focuses on intuitive eating and cognitive behavioral therapy to create sustainable and long-term changes in eating behavior. Visit Way at  , and on .  Reach out to Bentley at , and on . _______________________________________________________ For more episodes from Investor Connect, please visit the site at:    Check out our other podcasts here:   For Investors check out:   For Startups check out:   For eGuides check out:   For upcoming Events, check out    For Feedback please contact info@tencapital.group    Please , share, and leave a review. Music courtesy of .

This episode's Community Champion Sponsor is Catalyst. To virtually tour Catalyst and claim your space on campus, or host an upcoming event: CLICK HERE---Episode Overview: During this episode, we spend time with Josh Soldo, the Chief Scientific Officer at Veravas, and a healthcare innovator dedicated to developing diagnostic tests that enhance patient survival rates and reduce preventable medical tragedies. While together, Josh shares his personal and professional journey to entrepreneurship and why he is on a mission to revolutionize healthcare and improve patient care. We explore his deep industry expertise, the importance of networking, Veravas' exciting ventures, his company's strategic business model pivot, and Josh's vision for the industry's future. Join us to learn from Josh how he and the Veravas team are saving lives by transforming laboratory medicine! Let's go! Episode Highlights:Josh's deep industry experience that prepared him to help lead VeravasWhy networking is important to help discover new career opportunitiesWhat Josh and the Veravas team are most excited aboutHow Veravas pivoted their business model to meet market needsWhere Josh sees the industry heading over the coming years About our Guest: Josh Soldo is a healthcare innovator who has dedicated his career to developing diagnostic tests with the mission of giving patients a greater chance of survival and reducing the number of preventable medical tragedies. He has over 25 years of experience in diagnostic technology, product development, and commercialization in the life sciences industry, and he is a subject matter expert in solid phase chemistry, sample interference, and Vitamin D testing. He is a sought-after speaker and educator, and his research and patent portfolio include six granted US patents and over 50 international patents. His expertise in assay development and solid phase chemistry has been instrumental in his invention of Veravas' proprietary magnetic bead technology for sample interference elimination and biomarker enrichment. Josh has held numerous R&D and Scientific Affairs leadership roles over the past 20 years at Roche, Anteo Technologies, DiaSorin, and Beckman Coulter. He received the 2017 Roche Career Achievement Award for demonstrating continued commitment and achievement of excellence within Medical & Scientific Affairs, and the 2006 Beckman Coulter “Innovation in Technology” corporate award for his research to improve the quality and manufacturing scale of the Access immunoassays. At DiaSorin his teams developed and commercialized the market-leading LIAISON 25 OH Vitamin D Total Assay, and he was the principal inventor of the world's first fully automated, extraction-free immunoassay for the accurate detection of 1,25 Dihydroxyvitamin D. Josh's vision for Veravas is to continue leveraging its innovative VeraBIND technology platform to develop better diagnostics tools and treatments, ultimately improving patient care. Josh's leadership is playing a significant role in the company's success and has enabled Veravas to provide tools supporting the development of assays with unparalleled accuracy and sensitivity.Links Supporting This Episode:Veravas Website: CLICK HEREJosh Soldo LinkedIn page: CLICK HEREVeravas Twitter page: CLICK...

Throughout his career, Daniel J. Callahan has always been known as one of the top trial attorneys in California. His notable jury verdicts included a $934,000,000 jury verdict obtained after a three-month jury trial in a complex business dispute entitled Beckman Coulter vs. Flextronics. This unanimous verdict was the largest in California in 2003 and remains the largest in Orange County history. Mr. Callahan also went on to obtain a $50,000,000 settlement in a road design case against the City of Dana Point. Exclusive of large class actions, this continues to be the largest personal injury settlement in United States history. Mr. Callahan also obtained, after a two-month jury trial, a $38 Million settlement on behalf of a class of newspaper delivery drivers against The Orange County Register. This is still the highest employment settlement in Orange County's history. ************************************* About Neil Rockind - Neil Rockind is a trial lawyer. Neil Rockind is often considered a bet the farm/company type of lawyer, taking on cases where the stakes are “all in.” Neil Rockind appears regularly on television and in the news, defends people in serious court cases, is a regular guest on the Law and Crime Network and also discusses popular trials and cases and current events with other top lawyers around the country. Neil Rockind has won just about every award imaginable, has represented athletes, celebrities, musicians, posters and has obtained acquittals in all varieties of cases. His nickname is "The Rockweiler" and he's known for his cross examination style. Neil Rockind: https://twitter.com/neilrockindlawhttps://www.instagram.com/rockindlaw/https://www.rockindlaw.com/http://www.killercrossexamination.com/ ************************************* Subscribe to Killer Cross Examination® Podcast APPLE: https://podcasts.apple.com/us/podcast... SPOTIFY: https://open.spotify.com/show/424RIys... GOOGLE PODCASTS: https://podcasts.google.com/feed/aHR0... AUDIBLE: https://www.audible.com/pd/Podcast/B0... ****************************************** Fair Use Doctrine The contents are under fair use. It may contain copyrighted materials whose use has not been specifically authorized by the copyright owner. This, in our view, is fair use pursuant to section 107 of the US Copyright Law. Fair use allows limited use of copyrighted material without requiring permission from the rights holders, such as for commentary, criticism, news reporting, research, teaching or scholarship. We retain no rights to that material. To the extent the videos capture images or likenesses, we do not own the rights to those images, likenesses, etc and only use them pursuant to the fair use doctrine. All other rights are reserved. #crossexamination #BIGVerdicts #truecrime

In this episode, we're doing something a little different. Daniel Callahan joins me to discuss a case study in marketing mastery, and shares his best tips of what to do (and what not to do) that he has learned over the years.Daniel Callahan is the owner of Callahan Consulting Group LLC and the former President and Managing Partner of California's Premier Litigation Firm, Callahan & Blaine, headquartered in Santa Ana California. Throughout his career, Daniel J. Callahan has always been known as one of the top trial attorneys in California. His notable jury verdicts included a $934,000,000 jury verdict obtained after a three-month jury trial in a complex business dispute entitled Beckman Coulter vs. Flextronics. This unanimous verdict was the largest in California in 2003 and remains the largest in Orange County history.Daniel gives listeners actionable tips on: [4:15] How marketing has evolved over the years, and the tactics Daniel is still using today [6:05] How much time to put into traditional vs. online marketing [13:55] How to approach internet marketing [20:25] Marketing mistakes made over the years [22:35] Perfecting your elevator pitch [26:20] Daniel's book recommendation [35:00] One big takeaway from this episode Resources mentioned in this episode:Man's Search for Meaning by Victor FranklConnect with Daniel here: https://www.instagram.com/dancallahanconsulting/ https://www.linkedin.com/in/callahandaniel https://www.facebook.com/dancallahanconsulting https://callahanconsulting.com/ Connect with me Instagram Pinterest Facebook Twitter Karin on Twitter Karin on LinkedIn Conroy Creative Counsel on Facebook https://conroycreativecounsel.com

In this episode, we're doing something a little different. Daniel Callahan joins me to discuss a case study in marketing mastery, and shares his best tips of what to do (and what not to do) that he has learned over the years. Daniel Callahan is the owner of Callahan Consulting Group LLC and the former President and Managing Partner of California's Premier Litigation Firm, Callahan & Blaine, headquartered in Santa Ana California. Throughout his career, Daniel J. Callahan has always been known as one of the top trial attorneys in California. His notable jury verdicts included a $934,000,000 jury verdict obtained after a three-month jury trial in a complex business dispute entitled Beckman Coulter vs. Flextronics. This unanimous verdict was the largest in California in 2003 and remains the largest in Orange County history. Daniel gives listeners actionable tips on: [4:15] How marketing has evolved over the years, and the tactics Daniel is still using today [6:05] How much time to put into traditional vs. online marketing [13:55] How to approach internet marketing [20:25] Marketing mistakes made over the years [22:35] Perfecting your elevator pitch [26:20] Daniel's book recommendation [35:00] One big takeaway from this episode Resources mentioned in this episode: Man's Search for Meaning by Victor Frankl Connect with Daniel here: https://www.instagram.com/dancallahanconsulting/ https://www.linkedin.com/in/callahandaniel https://www.facebook.com/dancallahanconsulting https://callahanconsulting.com/ Connect with me Instagram Pinterest Facebook Twitter Karin on Twitter Karin on LinkedIn Conroy Creative Counsel on Facebook https://conroycreativecounsel.com

In this episode, we're doing something a little different. Daniel Callahan joins me to discuss a case study in marketing mastery, and shares his best tips of what to do (and what not to do) that he has learned over the years. Daniel Callahan is the owner of Callahan Consulting Group LLC and the former President and Managing Partner of California's Premier Litigation Firm, Callahan & Blaine, headquartered in Santa Ana California. Throughout his career, Daniel J. Callahan has always been known as one of the top trial attorneys in California. His notable jury verdicts included a $934,000,000 jury verdict obtained after a three-month jury trial in a complex business dispute entitled Beckman Coulter vs. Flextronics. This unanimous verdict was the largest in California in 2003 and remains the largest in Orange County history. Daniel gives listeners actionable tips on: [4:15] How marketing has evolved over the years, and the tactics Daniel is still using today [6:05] How much time to put into traditional vs. online marketing [13:55] How to approach internet marketing [20:25] Marketing mistakes made over the years [22:35] Perfecting your elevator pitch [26:20] Daniel's book recommendation [35:00] One big takeaway from this episode Resources mentioned in this episode: Man's Search for Meaning by Victor Frankl Connect with Daniel here: https://www.instagram.com/dancallahanconsulting/ https://www.linkedin.com/in/callahandaniel https://www.facebook.com/dancallahanconsulting https://callahanconsulting.com/ Connect with me Instagram Pinterest Facebook Twitter Karin on Twitter Karin on LinkedIn Conroy Creative Counsel on Facebook https://conroycreativecounsel.com

This week Steve and Yvonne interview Daniel Callahan, founding partner of Callahan & Blaine (https://www.callahan-law.com/)  and owner of Callahan Consulting (https://callahanconsulting.com/).   Remember to rate and review GTP in iTunes: Click Here to Rate and Review   View/Download Trial Documents   Guest Bio: Daniel Callahan Throughout his career, Daniel J. Callahan has always been known as one of the top trial attorneys in California.  His notable jury verdicts included a $934,000,000 jury verdict obtained after a three-month jury trial in a complex business dispute entitled Beckman Coulter vs. Flextronics. This unanimous verdict was the largest in California in 2003 and remains the largest in Orange County history. Mr. Callahan also went on to obtain a $50,000,000 settlement in a road design case against the City of Dana Point. Exclusive of large class actions, this continues to be the largest personal injury settlement in United States history. Mr. Callahan also obtained, after a two-month jury trial, a $38 Million settlement on behalf of a class of newspaper delivery drivers against The Orange County Register. This is still the highest employment settlement in Orange County's history. Mr. Callahan grew up in Chicago, Illinois where he went on to receive his BA, magna cum laude, from Western Illinois University in 1976, and graduated with honors from the UC Davis School of Law in 1979, while serving as Editor of the Law Review. He began his career in Hawaii before relocating to Southern California and starting his own firm by opening the doors on St. Patrick's Day, 1984. Mr. Callahan also provides corporate consulting to law firms and lawyers regarding litigation and strategy through Callahan Consulting Group, LLC. Read Full Bio Here   Show Sponsors: Legal Technology Services - LegalTechService.com Digital Law Marketing - DigitalLawMarketing.com Harris Lowry Manton LLP - hlmlawfirm.com   Free Resources: Stages Of A Jury Trial - Part 1 Stages Of A Jury Trial - Part 2

What you'll learn in this episode: Why preparation is the key to a successful career in law How Daniel has won some of the largest verdicts in history, even in supposedly impossible cases How making room for creativity can lead to better case outcomes Why focusing on current clients can be more beneficial than focusing on getting new business How to maximize your networking and business development efforts About Daniel Callahan Daniel Callahan opened his own law office on St. Patrick's Day in 1984. From there, he distinguished himself as one of the top trial attorneys in California and has repeatedly been recognized by his peers for his incredible accomplishments. Mr. Callahan was the winner of the prestigious OCTLA Trial Lawyer of the Year Award three times, in 2000, 2004, and 2012. Since founding Callahan & Blaine, Mr. Callahan has won many jury trials and obtained scores of seven and eight-figure settlements on behalf of his clients. Callahan Consulting: Callahan Consulting | Law Firm Consulting by Daniel Callahan - Instagram: Callahan Consulting Instagram Facebook: https://www.facebook.com/dancallahanconsulting Transcript: Daniel Callahan is a legendary California lawyer who has achieved record-setting verdicts for clients. What was the secret to his success? Preparation. By not putting off what he could do now, Daniel had the mental space to think about his cases creatively—and that led to astounding verdicts in seemingly impossible cases. He joined the Law Firm Marketing Catalyst Podcast to talk about his tips for building a network; why current clients are more valuable than new ones; and why client bills are an underused selling tool. Read the episode transcript here. Sharon: Welcome to the Law Firm Marketing Catalyst Podcast. Today, my guest is Daniel Callahan. He is founder and head of one of California's top litigation firms and has been a winner of the prestigious Orange Country Trial Lawyer of the Year three times. We'll learn all about his career path and why he thinks his firm is successful. Daniel, welcome to the program. Daniel:  Thank you very much, Sharon. It's nice to be here. Sharon: So glad to have you. Tell us about your career path. Daniel:  It's an unusual path, Sharon. When I left high school, I did not go to college directly. I went to work in construction because I didn't really apply myself much during school. I graduated fifth from the bottom in my class. So, I worked in construction. I was doing that. A buddy of mine got me a job, and I'm chopping trees down with my McCulloch chainsaw, and that turned me into a wood chopper. I'm thinking, “What am I doing here?” I saw my buddy. “I know why he's here, because he's standing next to his dad who got him the job. My mother and father told me I'd be a good lawyer. Maybe I want to try going to college after all.” Then, when I went to college, I thought, “O.K., now I'm with all those smart kids, so I have to work really hard.” I put them on a pedestal and worked really hard, and as a result, I had straight As through college. When I went to law school, I thought, “O.K., you were pretty good at college, but now you're really against all those smart guys.” Again, I put them on a pedestal, worked really hard and finished in the top 10 and editor of the law review. Then I went to law firms. I was recruited by several law firms. I went to Hawaii to practice initially with the oldest and largest firm in the state. I was there for two years. I learned a lot. I came back to California with another large law firm for another three years, and then I opened up my own shop. I was able to bring in more business than most people. I had enough to keep myself and two other associates busy, so I thought, “Maybe now is a good time to go out on my own.” I did that on St. Patrick's Day of 1984. Sharon: Wow! Let me go back for a minute. Why did your parents think you'd be a good lawyer? Daniel:  I think I was a bit argumentative. I could be kind of persuasive and argumentative at the same time. Sharon: Did you decide to go to Hawaii because that's where you wanted to be? Daniel:  No, not at all. I had never given a thought to Hawaii, but when they came to interview at the school, I accepted the interview and met with them. I got a call back. Two days later, they invited me to spend five days on the islands. They put me up at the Ilikai and gave me a car. In three days, you get to know the firm, and then you have two days to get used to Hawaii. It was so great! I took the job, but Hawaii wasn't really for me. I preferred being back in California, where I went to law school at UC Davis. I didn't go back to Davis, but I went to Newport Beach, California. Sharon: Was it more formal? Daniel:  It was a very large firm, and I would not say they were formal. They worked really hard, but they also played pretty hard. I got a good grounding from them. Sharon: It sounds like you have that, between everything you did. Tell us how that led to a couple of your biggest wins, because they're big. Daniel:  One of the things I learned from my mentor at Allen Matkins was you cannot be faulted for working too hard. Remember, I always put the opposition on a pedestal anyway. I want to be really prepared. They taught me how to be prepared, how not to put things off until tomorrow if you can do it today, because you don't know what's coming tomorrow. You may have an ex parte hearing; you may have something coming up. If you planned on doing this but you put it off, now you're crowded, and you can't do your best job. That's why I have been so successful. I almost over-prepare. When I go to trial, I prepare. First of all, someone else usually works up the depositions and the discovery and all that. They bring it to me and give me an idea which depos to read first. I read all the depos. I summarize the depos myself. I match them with all the exhibits that I read. Then I prepare the examinations of each witness, both our side and their side, linking them to the exhibits, and then I practice the exams. I work with the person who's in charge of my AV. When I want to do an exam, I want this coming up, and he's showing me how to put it up on the screen. When we go through these, after a while he knows everything I'm about to do, so you can almost think as I'm thinking. That's because of preparation. I also prepare my own opening statements. I go through them two or three times the day before or two days before it's scheduled. You don't want to do it too much because it gets kind of old. It still has to have some life to it, but you want to do it a few times to get the bugs out. If I have a group of people sitting in a conference room listening to me, they're instructed not to say a word during the opening, but after they can critique me. There is many a good idea I've gotten from those individuals. Some ideas I didn't think much of, and I did not incorporate them. Many ideas I did incorporate. When I walk into trial, I feel like the 800-pound gorilla because I'm really prepared. I have all the exams for the entire case done. The only thing I don't have done is a closing argument, and that's going to depend on the testimony. The attorneys who are listening to this should order a transcript of the trial and have a daily transcript. By the way, you should have it certified. If you don't have it certified, the judge may not allow you to use it. I believe in quoting the witnesses I cross-examine heavily. I believe in doing video depositions. You ask the same question three or four times. You get different responses. You pick out the response you like the best, and then you put a number of clips together and show that either during opening statement or right as you call that witness. Before you even ask him the question, you can play from his deposition. By that time, you've destroyed him in the eyes of the jury before he even gets to open his mouth. That is a helpful tip. I used that in one case called Beckman Coulter vs. Flextronics. That was a $2 million breach of contract case. We discovered a $300,000 fraud and we went to trial. Seven weeks into this trial, I amended the complaint to conform to proof that I had already elicited from the mouths of the defendants. I added two causes of action for economic duress, which is a subspecies of fraud. The jury came back and gave me $2 million on the first claim and $300,000 for fraud on the second, plus $1 million and a quarter of punitive. On the third cause, they gave me $180 million in punitive damages, and on the fourth $750 million in punitive damages, for a total of $934 million, which was and still remains the highest jury verdict in Orange County history. It was the highest in the United States up until about November of that year. How did that happen? Preparation, preparation, preparation. When you do that, when you are prepared, you can allow yourself to think, “What creative way can I go about doing this? How can I do something different?” By example, I had a smaller case called Radco v. Diamond Walnut. Radco was a producer of urethane foam, and they sent it to work sites in California in 55-gallon drums. They sold it to a subcontractor, but Radco wasn't paid. So, Radco calls me and says, “Dan, how do I get a mechanic's lien?” I said, “Well, in California, first you have to do a 20-day notice.” “A 20-day what?” “You have to give the owner notice ahead of time that you're providing materials to the job site, so he knows to get you paid. Where are these 55-gallon drums?” He said, “They're locked in a warehouse.” “Well, can you go get them, drive them around the block, release possession and then do a 20-day notice?” He has to do the notice within 20 days of releasing possession. “No, it's locked in a warehouse.” I thought through my conversation with him. He said he had sold to Midstate, a subcontractor who could not pay their bills as due. Well, that's the definition of insolvency. I remember from my days in law school studying the UCC that if you sold something to someone on credit while they're insolvent, you can reclaim those goods and get constructive possession. So, that's what we did. I got constructive possession back, even though the drums never left the warehouse. I then wrote a letter releasing that possession, served a 20-day notice and went for my mechanic's lien. The in-house counsel of Diamond Walnut said, “That is ridiculous.” There was no precedent for it, but I argued it to the judge in Stockton, and he agreed with me. As a result, Diamond Walnut had to pay twice for those materials. That is being creative. Sharon, if you don't mind, I think creativity is so important. You have to allow yourself enough time to be creative. Here's an example. I had a client who's an SBA lender. He lent money to this company in Orange County who had acquired all of this collateral, which the lender had a security interest in. The lender was not getting paid. He was afraid that if they did the normal due demand letter, filed a complaint, waited 30 days, all this collateral was going to wind up in Mexico. There are two ways to repossess collateral. There's a self-help repossession under UCC 9-503. That's what I did, but in order to make it look better, I put it on 14x11 paper, legal-size paper. I made it look like a form, although I filled it in with the correct statute, and then I had my signature notarized at the bottom, so now it really looks official. Then I went to the police department and said, “I need someone to come with me to make sure there's no breach of the peace.” He said, “I'll come with you to make sure you don't breach the peace.” This was back in the early 80s, when not everybody had a cell phone with a video camera. So, I hired a guy from Los Angeles to come film, and the three of us approached the back of the warehouse. There was an officer from the Irvine Police Department, myself and the videographer. The warehouse doors were all open, and I said, “Get that guy.” When I approached, I said, “My name is Dan Callahan and I represent the SBA. We're here to repossess a collateral of loans to the SBA. We're going to take the CEO down. If you want to be named in the lawsuit, you can go down too, but if you help me, if you identify the collateral right now, then we will let you go.” He went around identifying all the collateral that belonged to the SBA. One of the pieces of collateral was a forklift truck. We had a flatbed and a forklift, and we're loading all this stuff up on the flatbed. All of a sudden, our forklift ran out of gas. Fortunately, they had a forklift, so we picked up our forklift and everything else and left. We were out of there within about an hour. Whenever somebody came from the back room to look, we had the videographer shoot them, “I got you.” We went back to the office and had a beer with the client. I got a call from the lawyer representing the debtor, and he said, “Is it true all they had to do was say no?” I said, “Yeah, that's true.” He said, “Oh, my god. Congratulations on your sting.” The reason I tell you that, Sharon, is because that shows some creativity. On the other one, I grafted the UCC onto the mechanic's lien law. This one I went in on a self-help repossession, but I did a document. That is legal but somewhat deceiving. It looked like a court document almost. So, there are different things you can do creatively within the law that can get you results. Let me tell you one more story. There's a case I had where other lawyers had turned the case down. It's a personal injury lawsuit. There are these two women who were running in the bike lane, and they got hit by an uninsured drunk hit-and-run driver who abandoned his car. He was caught nine days later in a laundromat with beers in his pocket. He was sentenced to four years. The other lawyers who looked at this thought, “There's no money. Who are we going to sue? An uninsured hit-and-run driver?” I went to the site itself and looked where it happened, and I noticed the bike lane. There are regulations for this in California. Usually, the bike lane is about four-and-a-half feet wide. This lane is 11 feet wide. Also in California, it has to be a properly marked bike lane, and this was not. Ordinarily the government would have immunity, but only if they follow the engineer's advice. They had done it correctly many years before, but there had been a landslide covering the road. When they redid it and repaved it, they didn't do the bike lane properly. They didn't do it the way the engineer had told them many years before, so they did not have governmental immunity. So, I sued the City of Dana Point and demanded $50 million, which was the limit of their insurance. They offered me $30 million. I told everybody in my office, “We're not even talking about settlement. There is no settlement. You're not taking your foot off the gas.” For anybody who's listening to this, once people start talking about a settlement, there may be an inclination to take your foot off the gas. Don't do it. Just keep it there. On the Friday before the Monday trial, they said, “O.K., we're in. $50 million.” I got a call from an organization that tracks this, and they said, “Dan, that $50 million settlement is the highest personal injury settlement in the history of the United States.” Sharon: Wow! Daniel:  That's what I said, wow! They also said, “Oh, by the way, you also have the third highest.” I had one for $28 million. As it turns out, $28 million was third. $29 million had been the highest and became second. My $50 million took over. I don't know where that stands right now, but I'm sure it's pretty high up there. Sharon: You can tell just by looking at your website and all the badges and awards. Let me ask you this because you alluded to it. You said you do consulting. Daniel:  Yes. Sharon: Can you tell us a little about that? Daniel:  Yeah, certainly. I was a founder and managing partner of Callahan and Blaine, 28 attorneys in Santa Ana that do business litigation and personal injury. Now, I'm the CEO of Callahan Consulting. I consult with partners and associates from Callahan and Blaine, but also with other attorneys throughout the nation, giving trial practice and strategy advice. Also, I will be contacted by clients that are looking for a particular type of lawyer in a given community. Just last week, somebody needed a bankruptcy lawyer in Michigan. I researched it, and I found two really good lawyers. I presented them to the client. I arranged for a conference call between the client and each of these lawyers so the client could make up their own mind as to who they wanted to retain. I do this all throughout the United States. Usually, I get about one case a day that I'm trying to help somebody with. So, it's two things. I mentor attorneys, as I used to mentor the attorneys in my firm, and I also help clients find the attorney in the right specialty in their community that can help them. The way I'm compensated for this is normal. I get a referral fee when I set up a client with an attorney. I bill by the hour, and the hourly rate goes down. If you use more than five hours, then the hourly rate goes down. That's just getting at the strategy, how to work creatively to get the best result. One of the things that's helped me the most is looking outside the box. That's because I give myself enough time to be able to have that luxury, and that's because I don't put off until tomorrow what I can do today. It's the lessons you learn in your first few years. You get burned once and then you'll know. I was in trial one time, and I asked an associated to do a request for experts or expert designation. I came back from trial and asked, “Did you do it?” He says, “No, I didn't have time.” I go into the court to try to get relief the next day and he said, “No, it's too late.” So, I went to trial. I still won. I had to take their expert and turn him into my expert. So, you don't put things off. You get things done. Sharon: Would you say that's something you practice in the rest of your life as well as in the law? Daniel:  Yes, I would. I try to teach my children. I have my daughter, Caitlin, and my son, Michael, neither of whom are lawyers, but it's been drilled into them about preparation and its success and results. I think I practice that in many areas of my life. Sharon: Do you think you need to have these big wins to be successful? Can you be a successful personal injury firm without huge or noticeable wins? Daniel:  Oh yes, you can be successful without huge wins. Many attorneys spend a lot of time trying to bring in new clients, as well they should, but what you should also do is pay particular attention to the clients you have. Make sure you communicate often and clearly with your clients. Make sure they're comfortable with you at all times so they know what's coming and what to expect. When that happens, they're out there in the community talking about you, and then you get referrals through them. You build your base by working with existing clients who then will be more than happy to refer your business. If they perceive you as someone who cares about them, then they care about you. That's how I built my business. It was mostly from referrals from clients. Then it became referrals from other lawyers I knew, and then, because of the big victories, it became referrals from lawyers I never met but knew if they came to me, they were going to get a referral fee. It's better to get a referral fee on a $10 million victory than a referral fee on a $1 victory. So, people come to me for that reason, and I try my very best to deliver. Sharon: On your website you have both videos and a blog. Is it necessary to have both? Daniel:  10 years ago, I would have said no, but now, yes. Videos are very important. People now want to see a video. When they go to your website, they want to see a video, not just a bunch of doubletalk. They want to see what the person is like and how he reacts on film. Do they like him? Do they not? Certainly, you're going to pitch your wins and tell them what you can do for them. For blogs, it's the same thing. Blogs are very helpful. People are interested in listening or watching or reading to see if they can learn something. To get better at the very beginning, I would go to a lot of CEB courses because I figured I'm going to go there; I'm going to learn. I will always pick up something, and in the meantime, I'll meet a couple of people. We'll exchange business cards and I'll expand my network. You're in the back of the room, you get a cup of coffee, your doughnut, whatever they happen to have, and you meet people. You expand your network. Nowadays with the internet, people are expanding their networks all the time. But I find if it's a more personal touch, not just somebody I met on LinkedIn, it goes further. So, yes, I believe videos are important, blogs are important, personal touch is important. Get out there and meet people. Get out there and tell people what you do. If it's just a client, nobody's going to know about you. You've got to go ahead and show a little bit of what you have to offer. It's always a good idea to tell stories. When you tell a story to a prospective client about a case you won, that prospective client is putting himself or herself in the shoes of your client, thinking, “Damn, that's good. I wish that was me. I wish my attorney would do that for me.” I would go to parties and just talk to people at parties. That's how I would meet a lot of people. I'd tell a few stories and get them encouraged. Your light is always on. When you want to bring in business, your light should be on 24/7. If you go out somewhere, keep in mind you are a lawyer. If you encounter somebody, you should be able to tell them about it and tell them what you can do for them. You don't want to be pushy, of course, but when the opportunity comes, you are a salesman. Some lawyers I used to work with felt embarrassed about going out and trying to get business. They want to be a pure lawyer where they just research and write and argue to the court, but they don't go out to try to get business. Well, that person's not going to advance. That person is not going to advance in a partnership, because partners tend to look at what this person brings to the table, how much business he has, what kind of book he or she has. You have to always be developing that book, not just so you rise in the partnership, but also for your own well-being. If you have a large book of business with reliable clients, then you have a very good platform for further development. Sharon: Is that something a non-lawyer or a marketing director, let's say, should be saying to a lawyer? Have your light on all the time? Daniel:  Yes, definitely. 24/7, have your light on. Be awake. Be alert. You picked a profession. I'm very fortunate because I'm good at bringing in business, but I'm also good at trying cases. In fact, I'm really good at managing a law firm with the numbers and everything, what to spend money on, what not to spend money on and how to spend the money. I do all three, which is a gift. I didn't know I had that gift. When I used to chop trees down, I was a McCulloch chainsaw guy. It's something you learn and develop. If you work at it, you'll get it. Sharon: Do you think it's possible to learn the things you're talking about? How to develop business, how to manage a law firm, that sort of thing?  Daniel:  Obviously, when you manage a law firm, if you start out as a solo, it's not as difficult as stepping in and managing a 28-attorney law firm. There are classes you can take. You can also hire one or two competent people for your office. One is in charge of your accounting; one is in charge of secretarial. Then just manage it. Just make sure you get the bills out on time. Now, here's something. Here's basic 101. If you're working and billing by the hour, when do you write your time down on your timesheet? When you do the work. It's amazing how some people can leave at the end of the day and not have their timesheet filled out. They figure they're going to do it later. I've had attorneys working for me, and I just can't believe it. “What are you doing? Two weeks and you have not billed any time.” “No, but I have all my notes. I'm going to be doing my time.” That's ridiculous. You need to do it on a daily basis because when you do it on a daily basis, you can actually capture all the time. If you look back a week later, you really can't capture it, and you can't be specific enough to sell your information on the bill. When you do a bill, you should write the bill in such a way that the person reading it thinks, “Wow, that's a lot of work.” Don't give them shorthand, “A little research.” You should say what you've done so they know, “Man, that's a lot. O.K., I can see why they took an hour and a half,” or however long. Your bills need to be a persuasive piece of work, and when they're sent out, they have to be sent out timely. When you do something good for a client, they appreciate it, but the level of appreciation goes down over time. Let's say you do something for him or her on November 1. You get a bill out on December 10, and they go to pay it maybe in January. By January, their appreciation of what you did goes down. “Oh, really? I guess I could have done that myself.” Clients often appreciate you more at the beginning when you do the work, but if you delay too long—and some people delay a month or two months before sending out their bill. When they do send out their bill, it's not written like it's going to make you perspire to read it. It has to be written in a sales manner. You want the guy to read it, appreciate the work and pay the bill. Get it to him quickly and get it to him clearly. Sharon: It's something that persuades them. Do you think the aspect of business development—because that's what we're so involved in—can be taught? Daniel:  Yes, it can be taught. There are DVDs on it. There are many people that will try to teach you how to develop business. There are a lot of them out there. I've spoken to several over the years, and some of them are worth their salt. Sometimes I get a good tip or an idea. People will say you should have a 10-second commercial. When somebody says, “What do you do?” in an elevator, you can summarize what you do within the time it takes you to go from the 10th floor to the ground floor. That's called an elevator commercial. Those are helpful, but if people still have business cards now, you also need to exchange business cards or email or text or something, and then follow up on that meeting right away. Whoever you just met, wherever it was, just say, “It was a pleasure meeting you. I enjoyed learning about your son, your daughter, your business,” or whatever it had been, and then note that and follow up. Like I tell my son, you should log everybody you've met and put them into a calendar so you follow up in a week. Maybe it's, “Hey, by the way, I was thinking about you. I saw this may be relevant to your situation. Here's an email.” Maybe it's a phone call. It's just doing that again and again, and now you're expanding your network intelligently. You're not just getting somebody's business card and hoping he calls you. You're reaching out and talking to them about something that is of interest to them. When you talk to them, you don't want to just talk about yourself. You want to find out about their business, their family and what they do for entertainment or travel, whatever you can know. Then, as soon as you get back to your office or home, log all that in and calendar it to get back to this individual. If you do that, you can commit to making three—I'd say five, but even four—phone calls a day to people you met. Or if not a phone call, an email. It doesn't take that much time, but your network will grow huge. I don't know how many working days there are in a year, but if you made four phone calls or emails every working day, by the end of that year, you would have a network that's huge, which can pay off for you. When you want to bring in business, you've just got to reach out and touch somebody. Sharon: I would agree with you, but do you think it's true for the people who would rather research? They like the law, but they like it from a more academic perspective, let's say. Daniel:  Yes, I think they have to learn to adapt. I like the law. I like research and writing and arguing; however, I also like to have a comfortable lifestyle where I have a book of business that I can always rely on. That way, I'm more likely to make partner because I have a book of business. Also, I'm more likely to get more and more business. The people that say, “I love the beauty of the law,” that's good. We all do, but if that's all you've got, when hard times come, you may not be with the firm much longer. You can find dime-a-dozen lawyers that love the law, who think they're really good at it, that don't go out and do anything to generate business. That's not your best way to be a successful attorney.  Sharon: What is your one piece of advice to be a successful attorney? You may have said it already, but what advice would you give a new lawyer? Daniel:  Don't underestimate your opposition. In fact, you may want to put them on a pedestal and fight the guy on the pedestal. If you put the guy on a pedestal, you're preparing for Goliath. If Goliath doesn't show up, but you're ready for Goliath, you're going to have success. The keystone is prepare and don't delay. Don't put it off until tomorrow. Get it done, and get it done now. If you have an idea for something you think may work, write it down. When you have time to look at it more, maybe you can incorporate that into your action as a plaintiff or a defendant. By the way, I represent plaintiffs and defendants. I've only told you about the plaintiff wins. I have numerous defense wins, and I practice the same methodology. Sharon: Hopefully we can hear about those at another time. I want to thank you for being here today. Thank you so much. Daniel:  Sharon, I appreciate it. I'm happy to be here. Call me again anytime.

Mycology Immunoassays Testing Market: SnapshotThe rise in geriatric population and the increasing prevalence of chronic diseases stands as a key factor aiding in expansion of the global mycology immunoassays testing market growth during the forecast period, 2020-2030. The term mycology manages the investigation of the growth. In the event of determination of a contamination, microscopy, histopathology, and the utilization of the parasitic explicit stains have a significant job.For the correct treatment, precise and early determination of the disease should be made. With the assistance of the mycology, immunoassays test the growths can be portrayed rapidly and precisely. A mycology immunoassay test is an initial drug screen that detects how well the immune system of the body responds to the chemicals present in a sample. To distinguish the food hypersensitivities in the youngsters, the RIDA qLine® sensitivity test can be led which requires just a modest quantity of blood. In the single board, the screening of up to 20 allergens should be possible.Get Brochure of the Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=80213The report offers an intensive overview of the market and its growth parameters such as leading segments, growth drivers, repelling factors, current trends, upcoming growth opportunities. The market also emphasizes on the list of companies operating in the global mycology immunoassays testing market and what strategies are adopted by them in order to gain an upper hand in the overall market competition.The global mycology immunoassays testing market is classified on the basis of technology and end user. In terms of technology, the market is categorized into ELISPOT, polymerase chain reaction, ELISA, and rapid tests. With respect to end user, the market is divided into hospitals, research centers, blood banks, clinical laboratories, and research centers.Get Custom Research Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=80213Mycology Immunoassays Testing Market: Nature of CompetitionThe presence of multiple players has propelled the nature of the global mycology immunoassays testing market to be highly competitive. The entry of new players is further expected to intensify the overall market competition. Some companies are engaging in merger and acquisition, joint ventures, and other strategies in order to attract high revenues. Some other companies are investing heavily in research and development for testing quality improvement and analysis and to offer better products, thereby earning a high position in the market competition.Some of the notable vendors of the global mycology immunoassays testing market include bioMérieux SA, ELITech Group, Beckman Coulter, Inc., Abbott Laboratories, Inc., Siemens AG, Ortho-Clinical Diagnostics, Inc., F. Hoffmann-La Roche Ltd., MiraVista Diagnostics, and others.Get Custom Research Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=80213Mycology Immunoassays Testing Market: Current Tre

On this episode, Maxwell Goss speaks with legendary California litigator, Dan Callahan. Dan has the rare distinction of having achieved record verdicts and settlements in business, personal injury, insurance bad faith, and employment litigation. Dan discusses some of his biggest wins, including the $934 million jury verdict in a business contract and fraud case. Dan also talks about how he uses creativity and hard work to tackle what he calls “impossible" cases. ----- “I prepare to meet the big bad wolf, the Goliath, in the courtroom.So I make my opposition into Goliath.And when we show up in trial, they are not really Goliath.But we come prepared to beat Goliath, and that's why we get the results.”-Daniel Callahan----- 01:28 - About Dan Callahan and his law practice 05:52 – The importance of creativity in litigation 11:34 – Neria vs. The City of Dana Point 16:16 – The Beckman Coulter case 20:59 – What a $900M+ verdict did for Dan's law practice 21:48 – The Farmers Insurance case 23:43 – How Dan prepares for a case 26:53 – Dan's advice for litigators taking on difficult cases 29:02 – The importance of preparation in litigation 31:06 – Where to find Dan Callahan online ----- Daniel Callahan opened his own law office on St. Patrick's Day in 1984. Throughout his career, Daniel J. Callahan has always been known as one of the top trial attorneys in California. Daniel Callahan also provides corporate consulting to law firms and lawyers regarding litigation and strategy through Callahan Consulting Group LLC. Dan's notable jury verdicts included a $934,000,000 jury verdict obtained after a three-month jury trial in a complex business dispute entitled Beckman Coulter vs. Flextronics. This unanimous verdict was the largest in California in 2003 and remains the largest in Orange County history. He also went on to obtain a $50,000,000 settlement in a road design case against the City of Dana Point. Exclusive of large class actions, this continues to be the largest personal injury settlement in United States history. Dan also obtained, after a two-month jury trial, a $38 million settlement on behalf of a class of newspaper delivery drivers against The Orange County Register. This is still the highest employment settlement in Orange County's history. ----- https://www.youtube.com/watch?v=XlEB1sZ5xyg (Dan Callahan's “Mission Impossible” ad) https://callahanconsulting.com/ (Callahan Consulting) https://www.callahan-law.com/meet-the-team/daniel-j-callahan/ (Dan Callahan's Attorney Bio) https://www.insurance-litigation.cm/Verdicts-and-Settlements/Callahan-Blaine-Wins-934-Million-for-Beckman-Coulter.shtml (Callahan & Blaine Wins $934 Million Judgment) ----- The Litigation War Room is hosted by litigation lawyer Maxwell Goss. Max represents clients in intellectual property and business cases throughout Michigan and around the country, bringing forceful advocacy and creative solutions to every case he handles. ---------- https://www.thelitigationwarroom.com/ (Show Website) https://twitter.com/LitWarRoom (Twitter) https://www.linkedin.com/company/the-litigation-war-room-podcast/ (LinkedIn) https://www.facebook.com/The-Litigation-War-Room-Podcast-111235441143108 (Facebook)

both work in Beckman Coulter and talk about their recent attempt to climb Mount Blanc in memory of their late work colleague friend Dave McMahon. https://www.idonate.ie/fundraiser/MontBlancSummitAttempt  Interview originally broadcast as part of Saturday Chronicle Hosted by Marie McNamara and Trish Nugent on the 15th October  2022 Saturday Chronicle is Sponsored by JAMES M NASH Solicitors AND DERG KITCHEN DESIGN http://dergkitchendesign.ie   

An executive creative director, UX practitioner, brand strategist and visual designer who designs for the tech world but encourages everyone to always be designing their life. Lisa started her design life as a self-proclaimed creative through painting and photography, then regrettably sold all her work at a garage sale during a confidence crisis in her early 20s. She switched to graphic design and founded a web design studio where she was discovered online by Ernst & Young Consulting who were building a Center for Technology Enablement practice. After a rigorous stint building a bi-coastal team of creatives for the center, Lisa went on to find her place as an entrepreneur using a colorful mix of art, technology and business. She helped Hewlett Packard's education division build a global e-commerce experience. She opened an invitation company in Santa Barbara that was selected to be part of a television series for The Learning Channel focused on high-end wedding designers, their lifestyle and how they run their design business - winning features in InStyle, Destination Weddings and Your Wedding Day Magazines. Lisa led the brand and communication department at Stanford Law School, building an online solution recognized as a finalist by the Society for New Communications Research for Innovation of Year. She now runs an underground studio for her company called razpberrizoo creative where she strengthens brands, designs digital products and strategizes on UX for the likes of 20th Century Studios (Walt Disney), Stanford University, Jones Lang LaSalle, Farmgirl Flowers, First Republic Bank, Pfizer, Hewlett Packard, Beckman Coulter, CSC and Hot Topic. She also co-owns an early-stage AI-based health and wellness start-up where her team is attempting to change everyone's mindset about exercise. You can find out more at designinglisapeacock.com

lovethylawyer.comA transcript of this podcast is available at lovethylawyer.com. Throughout his career, Daniel J. Callahan has always been known as one of the top trial attorneys in California.  His notable jury verdicts included a $934,000,000 jury verdict obtained after a three-month jury trial in a complex business dispute entitled Beckman Coulter vs. Flextronics. This unanimous verdict was the largest in California in 2003 and remains the largest in Orange County history.Mr. Callahan grew up in Chicago, Illinois where he went on to receive his BA, magna cum laude, from Western Illinois University in 1976, and graduated with honors from the UC Davis School of Law in 1979, while serving as Editor of the Law Review. He began his career in Hawaii before relocating to Southern California and starting his own firm by opening the doors on St. Patrick's Day, 1984. Mr. Callahan also provides corporate consulting to law firms and lawyers regarding litigation and strategy through Callahan Consulting Group, LLC.Among his many accomplishments over the last 42 years of practice:Won the Largest Jury Verdict in Orange County History – $934 Million.Obtained the Highest Personal Injury Settlement in the history of the United States – $50 Million.Obtained the highest Insurance Bad Faith Judgment in Orange County History – $58 Million.Obtained the Largest Employment Judgment in Orange County History – $38 Million.Named One of the Top 10 Attorneys in the United States by National Law Journal.Voted California Business Trial Lawyer of the Year by California Lawyer Magazine.Named One of Top 10 Lawyers in Southern California by Super Lawyers.Winner of the Prestigious OCTLA Trial Lawyer of the Year Award – 2000, 2004 and 2012.Received Commendation Resolution from California Legislature Assembly, 2013.Received Commendation Resolution from California Senate, 2014.Best Lawyers in America, 2005 to 2021.Super Lawyers, Named One of The Top 100 Lawyers in Southern California – 2011 to 2021.CONTACT INFOEmail: dcallahan@callahan-law.comToll Free: (888) 284-0809Phone: (714) 241-4444Fax: (714) 241-4445Download VCard Louis Goodman www.louisgoodman.comhttps://www.lovethylawyer.com/ 510.582.9090  Musical theme by Joel Katz, Seaside Recording, Maui Technical support: Bryan Matheson, Skyline Studios, OaklandAudiograms & Transcripts: Paul Roberts   We'd love to hear from you.  Send me an email at louis@lovethylawyer.comPlease subscribe and listen. Then tell us who you want to hear and what areas of interest you'd like us to cover.  Please rate us and review us on Apple Podcasts.    

According to ISACA's new survey report, State of Cybersecurity 2022: Global Update on Workforce Efforts, Resources and Cyberoperations, organisations are struggling more than ever with hiring and retaining qualified cybersecurity professionals and managing skills gaps. The eight annual survey features insights from more than 2,000 cybersecurity professionals around the globe, and examines cybersecurity staffing and skills, resources, cyberthreats and cybersecurity maturity. We speak with Jonathan Brandt and Jenai Marinkovic on behalf of ISACA for a report deep-dive discussion. A copy of the report is available here https://mysecuritymarketplace.com/rep... Jonathan Brandt, CISM, CDPSE, CCISO, CISSP, CySA+, CPI, PMP A senior information security practice manager in ISACA's Knowledge and Research department. In this role, he contributes thought leadership by generating ideas and deliverables relevant to ISACA's constituents. He serves ISACA® departments as a subject matter expert on information security projects and leads author management teams whenever external resources are necessary. Brandt is a highly accomplished US Navy veteran with more than 25 years of experience spanning multidisciplinary security, cyberoperations and technical workforce development. Prior to joining ISACA, Brandt was a project manager for classified critical infrastructure projects across the globe. Jenai Marinkovic, vCTO/CISO, Tiro Security; Technology & Information Security Consultant, Beyond; member, ISACA Emerging Trends Working Group Jenai Marinkovic is a multidisciplinary technologist and strategist with 20 years of experience in architecting, building and securing systems at scale. She has designed and operated in real-time over the top streaming ecosystems that power live sports, gaming, and entertainment. She's also worked in biomedical manufacturing and laboratory diagnostics, healthcare tech and robotics in agriculture. Jenai's worked with artificial intelligence, its impact on diversity and inclusion as well as improving human empathy towards machines. She has expertise in designing the next generation security experiences necessary to support digital transformation She has built and run design, architecture, innovation, engineering, security and operations teams. Her security expertise spans security architecture, engineering, defense, and forensics and invented a cyber defense framework for large scale breaches based on American football. Jenai has worked for large enterprise brands including DIRECTV, Electronic Arts, Beckman Coulter and international investigations firms such as Kroll. About ISACA For more than 50 years, ISACA® (www.isaca.org) has advanced the best talent, expertise and learning in technology. ISACA equips individuals with knowledge, credentials, education and community to progress their careers and transform their organisations, and enables enterprises to train and build quality teams. ISACA is a global professional association and learning organisation that leverages the expertise of its more than 150,000 members who work in information security, governance, assurance, risk and privacy to drive innovation through technology. It has a presence in 188 countries, including more than 220 chapters worldwide. In 2020, ISACA launched One In Tech, a philanthropic foundation that supports IT education and career pathways for under-resourced, under-represented populations. Twitter: www.twitter.com/ISACANews LinkedIn: www.linkedin.com/company/isaca Facebook: www.facebook.com/ISACAGlobal Instagram: www.instagram.com/isacanews

Today's innovative medical technology is more like a video game and makes a minimally invasive ablation so easy it could be done by a 12-year-old.In this episode of the Global Medical Device Podcast, Jon Speer and Etienne Nichols talk to Mina Fahim, ​CEO and President of MediView, about bringing augmented reality (AR) medical technology to market.MediView gives clinicians X-ray vision and leverages AR and artificial intelligence (AI) to simplify, democratize, and inform healthcare delivery. Previously, Mina worked at Medtronic, Abbott, Beckman Coulter, and Excelen.Mina is a serial entrepreneur in the medtech and fintech spaces. He approaches his life with a foundation of trust, team, transparency, and track record to encourage collaboration and innovation focused on advancing people's everyday lives. Some of the highlights of this episode include:MediView solved the problem of how to place a 3-D representation of a patient's specific anatomy underneath the skin to millimeter accuracy.MediView's solution enables opportunities for digital health care for minimally invasive procedural guidance and data analytics.MediView's imaging technology and data feed its platform through a pre-operative or intraoperative scan, such as a CT or MRI, taken of the patient.The scan is communicated to a headset and an algorithm combines/lines up digital AR and physical coordinates to create a 3-D reconstruction that's put directly into and onto the patient.In the U.S., between physical therapy, loss of productivity, and time off, there's $120-billion of economic impact due to ergonomic injury of medical imaging.The first therapeutic area and clinical unmet need MediView is targeting is liver and kidney cancer. Only 1 or 2 patients receive a minimally invasive procedure, while the others have to go through chemotherapy or resection.Mina describes the differences of virtual reality (VR) versus AR. VR puts you in a fully digital world, while AR superimposes digital content onto the physical world.MediView's work culture materializes into the company's business strategy and model across four functions—trust, transparency, team, and track record. Memorable quotes from Mina Fahim:“We are hardware agnostic. So, we don't depend, actually, on any one specific headset because of the unique algorithms that we built in.”“We have an algorithm that combines the digital world in AR with the physical world.”“The interventionists are not comfortable taking a needle, sticking it into the abdomen, trying to hit a grape inside of a watermelon blindly to get that tumor ablated.”“We give clinicians imaging modalities they trust and are comfortable with today to validate the new way we're providing them to practice and exercise medicine.”“If a company's exit strategy is acquisition, having a robust QMS that someone can look at effectively, efficiently, and simply…that has a mental impact, an emotional impact, a burden impact."Links:Mina Fahim on LinkedInMediViewMedtronicMark GriswoldFDA - Medical Device OverviewCode of Federal Regulations (CFR)The Greenlight Guru True Quality Virtual SummitGreenlight Guru YouTube ChannelMedTech True Quality Stories PodcastGreenlight Guru

The LabOpp Global Leaders podcast is a series of conversations about Careers, the Lab Industry, Training, and People. In this episode, we meet Kelechi Ekwonwa. Kelechi shares his journey and his insights into the future of the medical lab. Have you noticed the advancing role of automation in your laboratory? Could it get to the point where humans are not required within the lab setting? What role would there be for MLS degree holders in that world? He examines this and more about the future of the medical laboratory in this week's episode. If you would like to get in touch with Kelechi, you can find him on LinkedIn. Some of the organizations mentioned during this podcast: · Ambrose Alli University https://aauekpoma.edu.ng/ · The University of Texas at Austin https://www.utexas.edu/ · Afriglobal https://www.afriglobalmedicare.com/ · Wellmed Healthcare https://www.wellmed.ng/ · Mindray www.mindray.com · Beckman Coulter www.beckmancoulter.com If you have suggestions for future guests or comments about this podcast, please visit us at labopp.org/podcast Thank you for leaving a rating and review to help us share this podcast! --- Send in a voice message: https://podcasters.spotify.com/pod/show/labopp/message

In part three of our four-part Women CEO & Founder Series, Proclinical Executive Senior Partner, Claire Perry, is in discussion with another great leader, Bonnie Anderson, Co-founder and Executive Chairwoman at Veracyte. Bonnie shares her journey of taking her start-up genomic diagnostics business through to a successful IPO, and her insights on transitioning from a private to public company. She also gives her thoughts on what executive-level women in the workplace can do to support the next generation of female leaders, how women can secure their first board role, and much more.Bonnie H. Anderson is Co-founder and Executive Chairwoman of Veracyte, a global diagnostics company that aims to transform outcomes for patients all over the world at every step of their journey in cancer and other diseases. Ms. Anderson's career spans over 40 years in regulated diagnostics and life science markets. She co-founded Veracyte in 2008 and served as Chief Executive Officer and Chair of the Board until June 1, 2021, when she assumed the role of Executive Chairwoman. Ms. Anderson led Veracyte's initial public offering in 2013, spearheaded commercialization of its market-leading products and was the architect of the company's vision to become a global enterprise, with a growing menu of advanced genomic diagnostics tests and its own distributed instrument platform. Prior to Veracyte, Ms. Anderson provided strategic consulting services to venture capital firms and early-stage businesses following 18 years in leadership positions at Beckman Coulter. She serves on the boards of Bruker Corporation, DNA Script, and the Biotechnology Innovation Organization (BIO), and is a trustee emeritus of the Keck Graduate Institute of Applied Life Sciences. Additionally, Ms. Anderson is President of the Coalition for 21st Century Medicine and previously served on the board of Castle Biosciences. She has received numerous awards for her industry leadership, including: the Wallace H. Coulter Award for Healthcare Innovation (2017); “Fiercest Women in Life Sciences” (FiercePharma, 2017); “100 Most Creative People in Business” (Fast Company, 2015); “Most Influential Women in Bay Area Business” and “Bay Area's Most Admired CEOs” (San Francisco Business Times, 2013 and 2014); and “Women of Influence” (Silicon Valley Business Journal, 2013). Under Ms. Anderson's leadership, Veracyte has been named a “Top Workplace” by the Bay Area News Group, based solely on employee feedback, for seven consecutive years (2014-2020). Ms. Anderson graduated from Indiana University of Pennsylvania with a B.S. in Medical Technology and in 2012 was honored with a “Distinguished Alumni” award. Topics covered:Establishing a company in an economic crisisChallenges of starting a businessWhen is the right time to IPOHow running a public company differs from running a private companyValuable lessons in running a successful profitable businessAdvice for securing your first board positionSupporting the next generation of female leadersContact the host and guest: Get in touch with Claire Perry:Email: c.perry@proclinical.comConnect with Claire on LinkedInConnect with Bonnie H. Anderson on LinkedIn More information:At Proclinical, our global workforce solutions help individuals, teams and whole organizations grow in the life sciences industry. For more information about how Proclinical Executive can support your board level and leadership hires, visit proclinical.com/executive

I was honored to host Ms. Topaz Kirlew, a Vice President of Regulatory Affairs at Integra LifeSciences, and formerly at Apyx Medical.Topaz has over 25+ years experience in Quality and Regulatory Affairs across Biologics, Drugs, Medical Devices and Tissue/Cell Based Products. She's had the opportunity to work for a diverse range of businesses from very larger corporations like Danaher, specifically with Beckman Coulter, to small, yet rapidly growing organizations like Apyx Medical.During this episode, we discussed various situations of Adversity that Topaz remarkably overcame to be the successful female Executive leader she is today.Today, Topaz serves as a Vice President of Regulatory Affairs at Integra LifeSciences where she is responsible for developing and implementing Integra's regulatory strategy while providing leadership over submissions, compliance, advertising and promotional review as well as product registrations across the product portfolio for all of Integra's products.We discussed:-Her early, formative years. Where she grew up, her family life, etc.-How she got into the LifeSciences, and specifically Regulatory Affairs-The challenges she faced rising up through the ranks as a woman of color-Her perspective on the role and responsibilities of both a mentor and a mentee...and so much more!

 This week Host Jim Collins is joined in studio by  Pat O'Brien. New chair of Killaloe Municipal District with local man Councillor Joe Cooney taking on the position for the second time.  Noel McNamara rugby coach has gone to South Africa to coach and recent events at Beckman Coulter as well as local updates on defibrillators. Hopes are high that the Mills can go one better in the Championship this year. Around the Parishes is sponsored by Tom Collins engineering.

Can you find spectacular success without experiencing your fair share of setbacks? On today's show, we interview Rob Lovato, territory sales executive, Beckman Coulter who shares with us his distilled wisdom on grit, excellence, and success.  Growing up, Rob was lucky to study in an extremely competitive high school, an experience that made him realize the importance of excellence and continuous improvement.  However, money was tight when he was about to enroll in college, and so he decided to go to Naval Academy instead. Life had different plans and Rob had to leave the academy midway due to a busted shoulder.  For a while, Rob had to attend community college and he ended up feeling demotivated and depressed owing to the poor quality of education.  This is when he ran into College Works.  Rob stayed with College Works from 2011 to 2017, an experience that funded his education at the University of Illinois, Urbana Champaign.  Currently, as an account manager with Beckman Coulter Diagnostics, Rob markets diagnostic medical equipment and is responsible for a territory generating $10M in annual revenues You will get a peek into the world of medical equipment and pharmaceutical sales. And learn about the critical attributes that have contributed to Rob's success.  Rob opens up his playbook and shares why spectacular success is not possible without making sacrifices.    What You Will Learn In This Show Understanding excellence and why it is a moving target Being persistent and overcoming setbacks How College Works can help you realize your life goals And so much more… Resources CollegeWorks Website Edge Of Excellence Bundle   Edge Of Excellence Is Brought To You By College Works Painting Internship College Works Paintings provides college and university students a unique, life-transforming opportunity to build business management and leadership skills, hands-on. The internship empowers students to run their own local businesses, manage their own crew of people, and provide a much-needed service within their communities - while earning money as well as an invaluable experience. Their internship allows students to not only gain valuable work experience but to help finance their college educations as well. The company is known for having some of the highest customer satisfaction ratings in the industry. To learn more: https://www.collegeworks.com/students-home-page/

In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Chris Hagen, vice president of the global COVID-19 task force and marketing for Beckman Coulter. He addresses a number of issues around the COVID-19 pandemic, from challenges with the ramp-up of production to securing needed supplies from a supply chain under stress. Hagen also speaks to the federal government’s response and how it affected diagnostic manufacturers. Specifically, the following questions are addressed.For those who don’t know what Beckman Coulter is, can you give a brief introduction?How has Beckman Coulter contributed to the fight against COVID-19?What was it like for a firm like Beckman Coulter to scale up manufacturing to meet the incredible demand for COVID-19 diagnostics?What was the impact of all those tests on the diagnostic infrastructure, such as the processing labs, and were the manufacturers able to aid with this portion in any way?How is the federal government trying to increase testing capability and what’s the impact on manufacturers?For Beckman Coulter, what are the lessons learned from the pandemic that you can carry forward?Listen to this episode and see what you think of the industry’s response to the need for COVID diagnostics. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.

This Industry Talk features Bonnie H. Anderson, the Chairman and Chief Executive Officer of Veracyte, a leading genomic diagnostics company that leverages deep genomic insights to transform care. Ms. Anderson’s career spans over 30 years in regulated diagnostics and life science markets. She cofounded Veracyte in 2008 and served as the company’s President and Chief Executive Officer until 2016, when she was also appointed Chairman of the Board. Prior to Veracyte, Ms. Anderson provided strategic consulting services to venture capital firms and early-stage businesses following 18 years in leadership positions at Beckman Coulter. Ms. Anderson is a trustee emeritus of KGI and graduated from Indiana University of Pennsylvania with a Bachelor of Science degree in Medical Technology. Under Ms. Anderson’s leadership, Veracyte has been named a “Top Workplace” by the Bay Area News Group, based solely on employee feedback, for seven consecutive years (2014-2020). Learn more about KGI: https://www.kgi.edu.  Learn more about Veracyte: https://www.veracyte.com. 

Steve Blanc is a senior-level healthcare sales executive with an accomplished record of success in commercializing innovative medical devices and services. Through his 33-year career at Beckman Coulter he held multiple positions in customer operations, leading the commercial sales teams. Over the last 12 years he served as Vice President and General Manager, North America Life Sciences, Worldwide Operations and the U.S. Diagnostic Customer Operations. Today, Steve consults and serves as a trusted advisor to several companies as a strategic and tactical specialist in leading sales teams and driving company growth. Among his current projects he is a Team Lead in the RADx -Tech NIH program working to bring Innovative COVID testing technologies and companies to market to address the pandemic. In addition to his professional accomplishments, Steve is a Big Brother and is on the Board for Big Brothers Big Sisters in Orange County and the Inland Empire, a Success Coach for Working Wardrobes, and an Ambassador for the Second Harvest Food Bank in Orange County Support the show: https://theanswersandiego.com/radioshow/8349 See omnystudio.com/listener for privacy information.

Kevin McKernan believes there are too many scientists paid from tax money, and that the free market would have handled the Coronavirus crisis much more precisely if the government had not intervened.  His controversial ideas are explained with detail and a level of understanding that is simply amazing.  I felt genuinely uncomfortable as he approached topics that are controversial, but his nuance made the conversation particularly compelling and interesting.Kevin is the CSO and Founder of Medicinal Genomics and has pioneered the genomics of cannabis and hemp to build a stronger scientific environment (Kannapedia.net) for the study of cannabis based therapeutics and blockchain technologies for tracking and verifying cannabis genetics. Previously, Kevin was the CSO of Courtagen Life Sciences, Inc., and was Vice President and Director of R&D of Life Technologies where he managed the development of Life Technologies next generation SOLiD sequencing technology. Integral to the SOLiD R&D process, Kevin oversaw over 100 research collaborations exploring the new biological frontiers with next generation sequencing and saw particular excitement and traction in human tumor sequencing. Kevin initiated an R&D project to investigate chemFET semiconductor based DNA sequencing and spearheaded a process to acquire the DNA sequencing company Ion Torrent for $350M. These collaborations resulted in hundreds of publications and 7 Journal covers from Science Translational Medicine to Nature.Kevin was the President and CSO of Agencourt Personal Genomics, a startup company he co-founded in 2005 to invent revolutionary sequencing technologies that dropped the cost of sequencing a human genome from $300M to $3,000; a 100,000-fold improvement in sequencing speed and cost in a few years.  In 2000, Kevin Co-Founded Agencourt Biosciences Corporation and acted as the CSO until it was acquired by Beckman Coulter. Kevin also managed the R&D for the Human Genome Project at Whitehead Institute/MIT resulting in several patents for nucleic acid purification. Kevin holds a B.S. in Biology from Emory University with a focus on cloning and expressing Norepinephrine Transporters.  When not decoding DNA and unraveling the mysteries of cannabis medicine, Kevin enjoy boating, skiing, and gardening.Kevin can be found on Twitter: @Kevin_McKernanVance can be found on Twitter: @Vance CroweWe spoke about videos on Kevin's YouTube channel:We also discussed @EricRWeinstein@nntaleb

135: Scott Kujak: Author of Underdog: True Stories of Overcoming Adversity, Podcast Host of Underdog, and Territory Sales Executive at Beckman Coulter, talks about how he overcame the low points of his life, from his wife leaving him to losing his friend and inspiration Phil Taylor to cancer.  Scott Kujak  Scott Kujak is an ex-college football player who has gone on to live a life of lifting up those that have faced adversities head on. Hear how the obstacles that prevented him from attending his first choice for college, Texas Christian University, where he had a partial academic scholarship and a preferred walk-on position on the football team waiting for him. “I actually grew up in an impoverished area in Florida and just with my own financial circumstances and my family dynamics I was not able to attend TCU and cover the rest of the tuition. So, I went to Eastern Illinois University where I had a full ride offer and went there and played quarterback. I was actually backup for Jimmy Garoppolo, who is the quarterback for the San Francisco 49ers right now.”    On this episode of Finding Your Summit Podcast, we talk with Scott Kujak, Author of Underdog: True Stories of Overcoming Adversity, Podcast Host of Underdog, and Territory Sales Executive at Beckman Coulter about his football experiences, and how his friend Phil Taylor, who died at age 25, was a huge inspiration when Scott was overcoming what he defined as the worst time of his life in 2016, when his ex-wife left him abruptly for good. “With Phil, he was also going through the worst time of his life. He was undergoing tremendous stomach pain and he didn't understand why. A couple of months later, he went to the doctor and they told him he had a large tumor blocking his large intestine. Although we were going through two separate scenarios, we experienced a lot of the same emotions of doubt and anger and ‘what the heck is going on?’ Yet, his reaction to those emotions was often much different than mine. He often looked at it in a way of positivity and optimism.”    What You Will Learn:   Scott Kujak talks about what he learned in terms of how to cope with adversity. “You can always make something good out of it. It doesn’t matter what you are going through. Cancer, someone dies in a car accident, you get walked out on, you have a devastating sports injury. No matter what the pain is that you face, whether it is physical, emotional, spiritual, you can respond in a way that makes a positive impact on the world.”    What did Scott’s friend Phil Taylor mean to him? “Phil is a perfect example of someone who touches your life and just had a profound impact that he knew during the last couple of years of his life. But he won’t know the huge impact because he passed away.”    Scott Kujak talks about how Phil Taylor helped inspire his podcast Underdog. “I thought, man, he has had such an immediate impact on his circle of friends and family. What if I got his message out there to the broader public. How do I do that? I thought of podcasts because I listen to a lot of podcasts, especially when I drive and I thought, I’m not just going to interview Phil and be done with it. Why don’t I interview people who have overcome many different types of adversity?”   What was it like having Chris Norton, who has also been a guest on Finding Your Summit Podcast, as a podcast guest on Scott’s show Underdog? “One of his PR people reached out to me and when I read about his story, I was like, ‘Oh my gosh. Yeah. He has got to come on the show.’ Chris was playing football in college, just like you and I. He was at a D3 school in Iowa, and he was on a kickoff team and went to make a tackle and everything changed for him in a second. Bad tackle gone wrong. He was paralysized from the neck down, never to really walk or live on his own again.”   What about Scott Kujak’s podcast is therapeutic for him? “Common ground. I think it lays a nice foundation of common ground between us and whoever we interview across the world because we realise no matter how big or how small the name is, the person that we are interviewing, there are very common emotions that we all go through that no matter what the situation is, we can empathize with them. We realise, hey, what I went through, maybe compares or doesn’t compare at all to what another person went through. Like they had it way worse and yet they responded in a much more positive way and I can try to emulate that.”      Scott’s Fiancé Scott Kujak went from heartbreak with the end of his prior marriage to having his heart reunited with love thanks to his new fiancé. “She has been nothing short of amazing and just filled with grace and patience and love for me and for many, many others. She is without a doubt a Godsend and an angel to me. She has lifted me up at times when I felt down and she supports me and is confident in the person that I am today and the man that I will continue to become in the future. We are getting married in April 2020. We are really, really, pumped about it. I would do anything in the world for her”      The Power of Faith During this episode of Finding Your Summit Podcast, Scott Kujak also highlights other amazing people that he has interviewed, many of the gems of advice that he has received from his podcast guests, and the power of his faith in God. “I love being in nature. It’s a huge reminder to me about how small I am here on planet Earth and how much I need God. How much I need my faith to carry on in life and do the things that God has put on my heart that He has only given me unique abilities to do, whether it is serving others or saying the right thing at the right time.”    Links to Additional Resources: Scott's website: scottkujak.com Scott's Linkedin

What does it take to commercialize new technology? Evan Tsang of Leap Biomed, a boutique medical device engineering and manufacturing firm, outlines the challenges entrepreneurs encounter and how to meet those challenges. Bio: Evan Tsang is currently Vice President, Business Development at Leap Biomed. Prior to this, he led engineering and product development teams at General Motors and Beckman Coulter before jumping into the startup world, where he has led multiple product development teams make the leap from idea to the clinic and beyond. Evan received his BS from Caltech in Mechanical Engineering and an MS from Oakland University in Industrial/Systems Engineering. http://www.weLeap.com https://www.linkedin.com/in/ectsang/

What does it take to commercialize new technology? Evan Tsang of Leap Biomed, a boutique medical device engineering and manufacturing firm, outlines the challenges entrepreneurs encounter and how to meet those challenges. Bio: Evan Tsang is currently Vice President, Business Development at Leap Biomed. Prior to this, he led engineering and product development teams at General Motors and Beckman Coulter before jumping into the startup world, where he has led multiple product development teams make the leap from idea to the clinic and beyond. Evan received his BS from Caltech in Mechanical Engineering and an MS from Oakland University in Industrial/Systems Engineering. http://www.weLeap.com https://www.linkedin.com/in/ectsang/

Join the conversation as Carol Lempert and I discuss networking, having BIG talk, rather than small talk, and how soft skills are actually the HARDER skills - and so necessary!If a psychiatrist and a cute librarian had a love child, it would Carol Lempert. Carol lives and breathes performance. She’s an award winning actress and playwright. (The New York Times has called her a “…resonant performer—with great humor.) She now specializes in helping business executives figure out what to say during high stakes—or ‘spot light’ moments—and how to say it.Carol is a sought after expert and has been quoted in Forbes, Reader’s Digest, the Financial Post and the Detroit Free Press. Clients include: Google, American Express, University of Michigan Ross School of Business, AT Kearney, Medidata Solutions, Beckman Coulter, Sciex, Danaher, and Harvard School of Business (yes THAT Harvard. Her mother is too proud.)Her most popular programs are: •Get Seen. Be Heard. Unlock Your Presence•Own Your Brand—Before It Owns You•Stories that Sell•Take the Guessworking out of Networking•No More Death By PowerPoint•Sabotage: The 7 mistakes Career Women MakeCarol received her Masters degree in Communication and Performance from York University. She lives with her husband; the comedian and improv master Scotty Watson, in a cozy home near the Hackensack River and has been known to eat Haagen Dazs ice cream for breakfast.www.CarolLempert.comemail: Info@CarolLempert.comhttps://www.linkedin.com/in/carollempert/https://www.facebook.com/CarolLempertSpeaking/On Twitter: @CarolLempertwww.mhnrnetwork.com

Join the conversation as Carol Lempert and I discuss leadership, and how to support your team (and yourself!) during the holidays.If a psychiatrist and a cute librarian had a love child, it would Carol Lempert. Carol lives and breathes performance. She’s an award winning actress and playwright. (The New York Times has called her a “…resonant performer—with great humor.) She now specializes in helping business executives figure out what to say during high stakes—or ‘spot light’ moments—and how to say it.Carol is a sought after expert and has been quoted in Forbes, Reader’s Digest, the Financial Post and the Detroit Free Press. Clients include: Google, American Express, University of Michigan Ross School of Business, AT Kearney, Medidata Solutions, Beckman Coulter, Sciex, Danaher, and Harvard School of Business (yes THAT Harvard. Her mother is too proud.)Her most popular programs are: •Get Seen. Be Heard. Unlock Your Presence•Own Your Brand—Before It Owns You•Stories that Sell•Take the Guessworking out of Networking•No More Death By PowerPoint•Sabotage: The 7 mistakes Career Women MakeCarol received her Masters degree in Communication and Performance from York University. She lives with her husband; the comedian and improv master Scotty Watson, in a cozy home near the Hackensack River and has been known to eat Haagen Dazs ice cream for breakfast.www.CarolLempert.comemail: Info@CarolLempert.comhttps://www.linkedin.com/in/carollempert/https://www.facebook.com/CarolLempertSpeaking/On Twitter: @CarolLempertwww.mhnrnetwork.com

On today's episode, we're introducing the newest addition to the greenlight.guru team, Jessica Lyons. Jessica is a 2007 graduate of Rose-Hulman Institute of Technology and has worked in the medical device product development for nearly 10 years. She worked in custom integration at Beckman Coulter, then worked on getting medical devices transferred to manufacturing at CRI, a medical device contract manufacture. Jon and Jessica are discussing FDA inspections. “It doesn't matter your size, shape or how long you've been around. You'll go through an FDA inspection.” – Jon Speer No one looks forward to having the FDA come to inspect their facility, but you always need to be ready for it, as you might be subject to an inspection as frequently as every two years. We want to put your mind at ease by giving you information on how to best prepare for FDA inspections, which can take a minimum of five to seven days. “The FDA seems to find the one piece of information you wish they wouldn't.” – Jessica Lyons Some of the topics you'll hear about it in today's podcast include: Jessica talks about her role at greenlight.guru, which is making sure the customers are successful, in whatever form that takes. - Why FDA inspections are high-stress. - How to prepare for an FDA inspection. - What to expect during your inspection? - Why the FDA nearly always finds potentially questionable items. - How to react if you receive a 483 warning letter. - What to do in order to resolve issues found during your inspection. - What FDA data is available to the public. Now if you liked today's episode, then I know you're going to find the free webinar we have coming up valuable. It's titled, “How to Avoid and Respond to FDA 483's and Warning Letters.” You can register for the webinar here: http://www.greenlight.guru/webinar/fda-483-warning-letter-response

On this episode of The Tatiana Show,  Tatiana and Josh speak with our returning guest, Kevin McKernan, about how he combatted hacked servers and secured his Medicinal Cannabis Genomics data using encrypted blockchain technology. These so-called “Honey Pot” data servers were trusted until they implemented their premeditated plan to steal their customers data in order to use it for competitive advantage. We also hear more about the newest science behind Cannabis Genetics - such as a brewing technique that integrates cannabis within a yeast strain. Stay tuned to learn the surprising bit about how psychoactive compounds are made - not grown organically. McKernan is an expert in the field of Cannabis Genomics and we are excited to share his amazing journey through one of the fastest-growing industries with our listeners. As always, thank you to our sponsors Vaultoro and SALT Lending.  Cheers! About the Guests: Kevin is the CSO and Founder of Medicinal Genomics and has pioneered the genomics of cannabis and hemp to build a stronger scientific environment (Kannapedia.net) for the study of cannabis based therapeutics and blockchain technologies for tracking and verifying cannabis genetics. Previously, Kevin was the CSO of Courtagen Life Sciences, Inc., and was Vice President and Director of R&D of Life Technologies where he managed the development of Life Technologies next generation SOLiD sequencing technology. Integral to the SOLiD R&D process, Kevin oversaw over 100 research collaborations exploring the new biological frontiers with next generation sequencing and saw particular excitement and traction in human tumor sequencing. Kevin initiated an R&D project to investigate chemFET semiconductor based DNA sequencing and spearheaded a process to acquire the DNA sequencing company Ion Torrent for $350M. These collaborations resulted in hundreds of publications and 7 Journal covers from Science Translational Medicine to Nature. Kevin was the President and CSO of Agencourt Personal Genomics, a startup company he co-founded in 2005 to invent revolutionary sequencing technologies that dropped the cost of sequencing a human genome from $300M to $3,000; a 100,000-fold improvement in sequencing speed and cost in a few years.  In 2000, Kevin Co-Founded Agencourt Biosciences Corporation and acted as the CSO until it was acquired by Beckman Coulter. Kevin also managed the R&D for the Human Genome Project at Whitehead Institute/MIT resulting in several patents for nucleic acid purification. Kevin holds a B.S. in Biology from Emory University with a focus on cloning and expressing Norepinephrine Transporters. When not decoding DNA and unraveling the mysteries of cannabis medicine, Kevin enjoy boating, skiing, and gardening.   If you like this content, please send a tip with BTC to: 1444meJi7YjgQGNg3U8Z6qYZFA5cgz4Gmj More Info:  MedicinalGenomics.com TatianaMoroz.com CryptoMediaHub.com Friends and Sponsors of the Show:  SaltLending.com/Tatiana Vaultoro.gold/tatiana Proof of Love Podcast *You have listened to the Tatiana Show.  This show may contain adult content, language, and humor and is intended for mature audiences.  If that’s not you, please stop listening. Nothing you hear on The Tatiana Show is intended as financial advice, legal advice, or really, anything other than entertainment.  Take everything you hear with a grain of salt. Oh, and if you’re hearing to us on an affiliate network, the ideas and views expressed on this show, are not necessarily of the those of the network you are listening on, or of any sponsors or any affiliate products you may hear about on the show.

A look each week at the town lands and parishes around North East Clare. This week, host Jim Collins talks to Pat O'Brien from O'Callaghans Mills who talks about all that’s going on in and around the Mills. Included in this weeks episode is news on the expansion at Beckman Coulter, re-election of local Councillor Joe Cooney. A recent walk took place throughout the Clare Hills area with over 120 walkers. Noel McNamara, manager of the U20 Irish rugby team came back to pay his own National school a visit. A look at Hurling and camogie activity by the parish teams as well.  Tune in locally every Saturday and Sunday between 9am and 9pm on 88.3FM, 92.7FM online on www.scariffbayradio.com or on your smartphone or tablet via the TuneIn Radio App.

Ralph is responsible for the day-to-day management and strategy for the region. Ralph is responsible for strategic growth of the flow cytometry and Latin America business within Sysmex. Since joining in 2007, Ralph has delivered a high level of clinical product innovation, business development, and customer care. His accomplishments include leading the team responsible for bringing to market the XN-Series analyzer in the Americas, a scalable, automated laboratory solution that was quickly adopted in the hematology marketplace, which grew the Sysmex market share in the U.S. and Latin America. Early in his career at Sysmex, Ralph established the first scientific marketing group and through the years led numerous strategic partnerships for Sysmex America, Inc. Prior to joining Sysmex, Ralph served as Vice President of Cellular Analysis Strategic Marketing at Beckman Coulter, formerly the Coulter Corporation, where he worked for nineteen years. Ralph is active in community/industry associations and has served as a member of the MBA industry advisory board for FIU, in Florida. Mr. Taylor is also a Board Member of AdvaMed Dx. He holds a graduate management degree from the University of Greenwich, London and an undergraduate degree in Medical Laboratory Sciences from Paddington College, London.

Highlights include: • Sequencing the cannabis genome • The process of submitting a project for funding from the Dash DAO • The banking crisis in the cannabis industry • Medical marijuana and CBD oil • Obstacles posed to the cannabis industry by the US government • Will the Trump administration legalize cannabis? • How blockchain can become part of popular culture • Reclaiming the mainstream narrative of bitcoin and blockchain technology • The recent Facebook purge and alternative social media platforms We’re moving to a new audio format! While I enjoy seeing the lovely faces of all my guests, we are trying some new things for The Tatiana Show. Audio-only enables me to work with less bandwidth while I’m recording shows on the road, and makes for easier editing. This means listeners will get more regular, top quality episodes! Thank you always to The Tatiana Show sponsors: Stamps.com, The Bitcoin CPA, CryptoCompare, and my marketing company, Crypto Media Hub. Kevin Mckernan kicks off this episode and treats us to his extraordinary range of knowledge and experiences from the cannabis and cryptocurrency spaces. Kevin has spent his career researching and developing various DNA sequencing technologies in both the research and clinical industries. He is the CSO and Founder of Medicinal Genomics. Kevin explains how he obtained funding for his cannabis genome sequencing project from the Dash DAO. For people who don’t know, Dash is a cryptocurrency that not only uses its fees to pay miners, like Bitcoin does, but also puts tokens from its fees into a treasury. People can then propose projects to Dash stakeholders and receive money from that fund. The Patent and Trade Office (PTO) has posed various obstacles to the cannabis industry, particularly through a controversial and overly broad patent issued in 2015, which Kevin helped to oppose. We also discuss the banking crisis in cannabis and in general how governments have stifled cannabis research and innovation for generations. Mckernan explains that “through prohibition, everyone started breeding for high THC, and that has come at the cost of all the other cannabinoids not being made” (20:23). There are rarer cannabinoids, with more therapeutic effects. Kevin and his team targeted one of those rarer strains to sequence for their Dash project. We also delve into some examples of diseases and ailments that can be aided by cannabis and CBD oils. At 24:00, Kevin treats us to a brief world history of cannabis, discussing how different strains originated in different parts of the world. The earliest cannabis was present 20 million years ago in the Hindu Kush mountain range. Ancient people grew hemp for its fibers, which were useful for making sails for their ships. Do you think the Trump administration will legalize marijuana? We discuss how new cannabis industries have affected the American economy and how Canada’s recent legalization of cannabis could force the Trump administration’s hand in U.S. policy-making (34:00). Kevin’s event is Cannmed, currently taking place at UCLA this week. Next we’re joined by Naomi Brockwell (37:30). Naomi is a film and television producer for John Stossel; she also hosts her own Youtube show on blockchain, bitcoin, and technology. Her newest project is a crypto thriller noir series called Hard Fork. She discovered the project through Steemit, where she connected with Doug Karr, an alumni of the Sundance festival, and Christopher James Baker (of the television series, Ozarks) as they were putting together this blockchain sci fi thriller. Like Kevin McKernan, they also received funding from the Dash DAO, and they’ve raised their first million dollars. The show is still in development. They will go into production and are hoping for a release at the end of 2019. Follow Naomi on social media (@NaomiBrockwell) or check out hardforkentertainment.io to stay updated. Naomi says of the Hard Fork series: “I wanted to get involved because all you hear about with crypto is the negative. ‘Oh it’s a bubble. Everyone in crypto is a loser.’ The mainstream media just talks about the drug dealers and money launderers and how they’re awful. But blockchain is the most empowering technology we’ve seen in the last hundred years. This is a way to decentralize trust. This is a way to completely revolutionize the traditional financial sector. Please do not discount this. Let’s talk about all the ways that this can change lives, how this can give people back more freedom, more financial autonomy. So I think getting in control of that narrative and creating a mainstream-audience-accessible series that actually looks at the way this can be a really empowering tech is what drew me to the project.” Cheers to that! Naomi came to cryptocurrency from a background in Austrian economics, in which economists like F.A. Hayek were eerily prescient about cryptocurrency. Speaking of economics, I’ll be seeing Naomi next on the Contra Cruise! Comment below if you’ll be there. Josh is missing out, but he’s helping with the Bitcoin Lightning Network Hack Day in New York. (56:00) Finally, we discuss Steemit, alternative social media, the recent Facebook purge of many libertarian pages and outlets, and how other activists have struggled with banning on various platforms. Naomi is a big fan of BitChute, an alternative to Youtube. If you’re interested in more on these topics, check out another recent episode of The Tatiana Show, in which I interviewed Bill Ottman of Minds.com and Matt Asher of BeforeTheBan.com. Thanks so much to my co-host Joshua Scigala, and our awesome guests! We hope you enjoy the episode! About the Guests: Kevin has spent his career researching and developing various DNA sequencing technologies in both the research and clinical industries. Additionally, Kevin has had a parallel interest in driving the tools used for personalized medicine into the world of cannabis medicine. Kevin believes the intersection of personalized medicine, genomics, blockchains and cannabis is one of the most exciting growth opportunities in our lifetime. Kevin is the CSO and Founder of Medicinal Genomics and has pioneered the genomics of cannabis and hemp to build a stronger scientific environment (Kannapedia.net) for the study of cannabis based therapeutics and blockchain technologies for tracking and verifying cannabis genetics. Previously, Kevin was the CSO of Courtagen Life Sciences, Inc., and held the position of Vice President and Director of R&D of Life Technologies where he managed the development of Life Technologies next generation SOLID sequencing technology. Integral to the SOLID R&D process, Kevin oversaw over 100 research collaborations exploring the new biological frontiers with next generation sequencing and saw particular excitement and traction in human tumor sequencing. Kevin initiated an R&D project to investigate chemFET semiconductor based DNA sequencing and spearheaded a process to acquire the DNA sequencing  company Ion Torrent for $350M. These collaborations resulted in hundreds of publications and 7 journal covers from Science Translational Medicine to Nature. Kevin was the President and CSO of Agencourt Personal Genomics, a startup company he co-founded in 2005 to invent revolutionary sequencing technologies that dropped the cost of sequencing a human genome from $300M to $3,000; a 100,000-fold improvement in sequencing speed and cost in a few years. Kevin oversaw the growth and research of APG until it was sold to Applied BioSystems. In 2000, Kevin Co-Founded Agencourt Biosciences Corporation and acted as the CSO until 2005 where it was acquired by Beckman Coulter. From 1996 to 2000 Kevin managed the Research and Development for the Human Genome Project at Whitehead Institute/MIT resulting in several patents for nucleic acid purification. Kevin holds a B.S. in Biology from Emory University with a focus on cloning and expressing Norepinephrine Transporters. When not decoding DNA and unraveling the mysteries of cannabis medicine, Kevin enjoys boating, skiing, and gardening. Naomi Brockwell is a film and television producer, and host of the show "Bitcoin, Blockchain, and the Technologies of our Future". She is a producer for Stossel, a producer for the TV series HardFork, and formerly produced for Fox Business Network and Fox News Channel. Naomi is the co-founder of The Soho Forum, on the Advisory Council at the Mannkal Economic Education Foundation, and in 2017 was awarded Uber's "Young Libertarian of the Year" at the Friedman Conference. She has produced numerous award-winning feature films, including the 2015 feature documentary Bitcoin: The End of Money as We Know It (Best International Documentary, Anthem Film Festival; Winner of Special Jury Prize, Amsterdam Film Festival), Audition (Best documentary, Lone Star Film Festival) and the Lionsgate thriller, Subconscious. Check out her daily videos at Youtube.com/NaomiBrockwellTV If you like this content, please send a tip with BTC to: 1444meJi7YjgQGNg3U8Z6qYZFA5cgz4Gmj More Info: TatianaMoroz.com CryptoMediaHub.com Medicinalgenomics.com Cannmedevents.com Osf.io/7d968/ Bigbudsmag.com/will-jamaican-lion-save-the-cannabis-industry-from-patent-trolls/ Dashforcenews.com/dash-labs-exclusive-update-interview-with-tito-rios-on-data-collection-protocol/  Youtube.com/channel/UCD-8zwMuJMW_Rf9xw3SF4Ew Hardforkentertainment.io Youtube.com/NaomiBrockwellTV Friends and Sponsors of the Show: TheBitcoinCPA.com CryptoCompare.com Stamps.com

Our episode 5 guest, Barbara Bucklin, Ph.D. talks about how she improves workflow and motivation in organizations. Barbara is an insightful Ph.D.-level learning and performance-improvement professional with over 15 years of experience. She specializes in linking performance solutions to organizational and business needs, analyzing performance to identify gaps between current and desired states, designing effective, engaging solutions to address real-world performance and business needs, and measuring solutions to determine if behavior changed and business results improved. She has worked with a diverse group of clients including Audi, Abbott, Barnes and Noble, Beckman Coulter, BMW, Ford, Honda/Acura, Hyundai, La-Z-Boy, Jaguar/Land Rover, Kia, Mazda, Nissan/Infiniti, Pandora Radio, Platinum Guild, Pfizer, Tiffany & Co, Volvo, Wyeth, and Weight Watchers. Learn more about Barbara Bucklin, Ph.D. For Business Leaders, By Business Leaders is a weekly podcast series brought to you by Lead2Goals, a business management consulting firm based in San Clemente, California. Learn more by visiting www.lead2goals.com.

On today’s episode, we’re introducing the newest addition to the greenlight.guru team, Jessica Lyons. Jessica is a 2007 graduate of Rose-Hulman Institute of Technology and has worked in the medical device product development for nearly 10 years. She worked in custom integration at Beckman Coulter, then worked on getting medical devices transferred to manufacturing at CRI, a medical device contract manufacture. Jon and Jessica are discussing FDA inspections. “It doesn’t matter your size, shape or how long you’ve been around. You’ll go through an FDA inspection.” – Jon Speer No one looks forward to having the FDA come to inspect their facility, but you always need to be ready for it, as you might be subject to an inspection as frequently as every two years. We want to put your mind at ease by giving you information on how to best prepare for FDA inspections, which can take a minimum of five to seven days. “The FDA seems to find the one piece of information you wish they wouldn’t.” – Jessica Lyons Some of the topics you’ll hear about it in today’s podcast include: Jessica talks about her role at greenlight.guru, which is making sure the customers are successful, in whatever form that takes. - Why FDA inspections are high-stress. - How to prepare for an FDA inspection. - What to expect during your inspection? - Why the FDA nearly always finds potentially questionable items. - How to react if you receive a 483 warning letter. - What to do in order to resolve issues found during your inspection. - What FDA data is available to the public. Now if you liked today’s episode, then I know you’re going to find the free webinar we have coming up valuable. It’s titled, “How to Avoid and Respond to FDA 483’s and Warning Letters.” You can register for the webinar here: http://www.greenlight.guru/webinar/fda-483-warning-letter-response

Background: Gastrointestinal cancer antigen CA19-9 is known as a valuable marker for the management of patients with pancreatic cancer. Methods: The analytical and clinical performance of the Access(R) GI Monitor assay (Beckman Coulter) was evaluated on the UniCel(R) Dxl 800 Immunoassay System at five different European sites and compared with a reference method, defined as CA19-9 on the Elecsys System (Roche Diagnostics). Results: Total imprecision (%CV) of the GI Monitor ranged between 3.4% and 7.7%, and inter-laboratory reproducibility between 3.6% and 4.0%. Linearity upon dilution showed a mean recovery of 97.4% (SD+7.2%). Endogenous interferents had no influence on GI Monitor levels (mean recoveries: hemoglobin 103%, bilirubin 106%, triglycerides 106%). There was no high-dose hook effect up to 115,000 kU/L. Clinical performance investigated in sera from 1811 individuals showed a good correlation between the Access' GI Monitor and Elecsys CA19-9 (R = 0.959, slope = 1.004, intercept +0.17). GI Monitor serum levels were low in healthy individuals (n = 267, median = 6.0 kU/L, 95th percentile = 23.1 kU/L), higher in individuals with various benign diseases (n = 550, medians = 5.8-13.4 kU/L, 95th percentiles = 30.1-195.5 kU/L) and even higher in individuals suffering from various cancers (n = 995, medians = 8.4-233.8 kU/L, 95th percentiles = 53.7-13,902 kU/L). Optimal diagnostic accuracy for cancer detection against the relevant benign control group by the GI Monitor was found for pancreatic cancer {[}area under the curve (AUC) 0.83]. Results for the reference CA19-9 assay were comparable (AUC 0.85). Conclusions: The Access(R) GI Monitor provides very good methodological characteristics and demonstrates an excellent analytical and clinical correlation with the Elecsys CA19-9. The GI Monitor shows the best diagnostic accuracy in pancreatic cancer. Our results also suggest a clinical value of the GI Monitor in other cancers.